We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
Cap. Flow
+$7.27B
Cap. Flow %
9.7%
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$3.04B
2
MSFT icon
Microsoft
MSFT
+$830M
3
AMZN icon
Amazon
AMZN
+$550M
4
JNJ icon
Johnson & Johnson
JNJ
+$483M
5
AAPL icon
Apple
AAPL
+$470M

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 13.75%
3 Healthcare 12.4%
4 Financials 7.81%
5 Industrials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTRE icon
226
CareTrust REIT
CTRE
$10.2B
$62.1M 0.08%
2,472,973
-165,058
-6% -$4.09M
REGN icon
227
Regeneron Pharmaceuticals
REGN
$68.8B
$61.9M 0.08%
58,873
-141,514
-71% -$137M
IBN icon
228
ICICI Bank
IBN
$106B
$61.4M 0.08%
2,130,832
+2,101,932
+7,273% +$56.3M
LULU icon
229
lululemon athletica
LULU
$13B
$61.1M 0.08%
204,500
+194,344
+1,914% +$65M
WAL icon
230
Western Alliance Bancorporation
WAL
$9.07B
$60.4M 0.08%
961,412
+116,322
+14% +$7.04M
TIP icon
231
iShares TIPS Bond ETF
TIP
$14.5B
$60M 0.08%
561,570
+16,839
+3% +$1.79M
PEP icon
232
PUT
PepsiCo
PEP
$186B
$59.9M 0.08%
363,000
+296,300
+444% +$51.1M
VRTX icon
233
Vertex Pharmaceuticals
VRTX
$121B
$59.5M 0.08%
127,000
-60,139
-32% -$26.1M
ONTO icon
234
Onto Innovation
ONTO
$13.6B
$59.1M 0.08%
269,387
+49,992
+23% +$10.3M
CHRD icon
235
Chord Energy
CHRD
$7.79B
$58.2M 0.08%
347,316
+129,539
+59% +$23M
EQH icon
236
Equitable Holdings
EQH
$13.1B
$57.7M 0.08%
1,412,269
+43,077
+3% +$1.69M
DKS icon
237
Dick's Sporting Goods
DKS
$18.4B
$57.1M 0.08%
265,687
-115,974
-30% -$24.2M
MRUS
238
DELISTED
Merus
MRUS
$56.7M 0.08%
957,952
+853,060
+813% +$41.3M
AA icon
239
Alcoa
AA
$11.7B
$56.6M 0.08%
1,422,797
+1,259,430
+771% +$48.7M
DNLI icon
240
Denali Therapeutics
DNLI
$3.67B
$56.2M 0.08%
2,418,833
+272,454
+13% +$5.23M
TRMD icon
241
TORM
TRMD
$3.1B
$55.4M 0.07%
1,429,989
+1,281,176
+861% +$45.9M
TEL icon
242
TE Connectivity
TEL
$58.8B
$55.1M 0.07%
366,054
-61,257
-14% -$8.98M
DUOL icon
243
Duolingo
DUOL
$5.7B
$54.6M 0.07%
261,692
-46,117
-15% -$9.44M
RDDT icon
244
Reddit
RDDT
$32.5B
$54.2M 0.07%
847,929
+457,588
+117% +$24.1M
XENE icon
245
Xenon Pharmaceuticals
XENE
$6.32B
$54M 0.07%
1,384,674
-65,668
-5% -$2.62M
WDC icon
246
Western Digital
WDC
$179B
$53.8M 0.07%
938,518
+706,705
+305% +$39.2M
TME icon
247
Tencent Music
TME
$14.5B
$53.7M 0.07%
3,818,652
-9,014,995
-70% -$121M
DDOG icon
248
CALL
Datadog
DDOG
$87.9B
$53.3M 0.07%
+410,600
New +$49.7M
ZIM icon
249
ZIM Integrated Shipping Services
ZIM
$3B
$53.1M 0.07%
2,397,311
+2,072,715
+639% +$33.5M
MHK icon
250
Mohawk Industries
MHK
$6.9B
$52.5M 0.07%
462,226
-33,886
-7% -$3.94M

Similar funds

Marshall Wace's Q2 2024 Portfolio in Review

As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.

  • Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
  • Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
  • Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
  • Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
  • Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
  • Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.